ADMA Biologics Inc (ADMA) — Cash Flow Reinvestment Rate
ADMA Biologics Inc (ADMA) has a Cash Flow Reinvestment Rate of 0.04x as of March 2026, reinvesting $2.54 Million (capex $2.54 Million ) from operating cash flow of $58.25 Million. Explore ADMA capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ADMA Biologics Inc Cash Flow Reinvestment Rate (2023–2025)
Historical reinvestment intensity for ADMA Biologics Inc across 3 annual periods. Also explore total assets of ADMA Biologics Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for ADMA Biologics Inc (2023–2025)
Year-by-year capital reinvestment analysis for ADMA Biologics Inc. For live market cap and broader valuation context, see market cap of ADMA Biologics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.45x | $22.57 Million | $50.40 Million | $22.57 Million | ▲ +210.0% |
| 2024 | 0.14x | $17.15 Million | $118.67 Million | $8.57 Million | ▼ -89.7% |
| 2023 | 1.40x | $12.30 Million | $8.80 Million | $4.98 Million | — |